IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGG ELISA— 510(k) K030701

Substantially Equivalent

Immco Diagnostics, Inc.

FDA 510(k) clearance K030701 for IMMULISA ANTI-BETA2 GLYCOPROTEIN I (B2GP1) IGG ELISA, Substantially Equivalent on 2003-09-09. Applicant: Immco Diagnostics, Inc..

Clearance details

Applicant: Immco Diagnostics, Inc.
Product code: Code MSV
Advisory panel: Immunology
Date received: 2003-03-06
Decision date: 2003-09-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Buffalo, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.